Skip to content

Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With ADRD

Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With Alzheimer's Disease and Related Dementias (TACTICs): A Pilot Randomized Controlled Trial (RRF)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04780178
Acronym
(TACTICs)
Enrollment
60
Registered
2021-03-03
Start date
2021-04-01
Completion date
2022-08-08
Last updated
2022-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Caregiver Burden

Keywords

Dementia, Alzheimer's disease, Caregiving, Caregiver, Anxiety, Telehealth

Brief summary

The purpose of the study is to test if Acceptance and Commitment Therapy (ACT), a behavioral intervention designed to increase psychological flexibility in the face of challenges, reduces anxiety associated psychological distress in dementia caregivers compared to the control group who will receive self-help and educational materials. This version of ACT is delivered over the phone in six primary sessions and one booster session.

Interventions

BEHAVIORALTelephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults with Alzheimer's Disease and Related Dementias

A telephone-based acceptance and commitment therapy for caregivers

Sponsors

Cleveland State University
CollaboratorOTHER
Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessors are blinded to participant group assignment.

Intervention model description

Participants will be randomly assigned to receive either the TACTICs telephone therapy or the minimally enhanced usual care packet of information.

Eligibility

Sex/Gender
ALL
Age
21 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Listed in ADRD patient's chart as primary caregiver or self-identifies as ADRD patient's primary caregiver * Intends to continue caregiving for ≥12 months * Clinically-significant anxiety (score ≥10 on GAD-7) * 21 years or older * Able to communicate in English * Able to provide informed consent

Exclusion criteria

* Caregiver is a non-family member * Care recipient is in an assisted living or nursing home (at baseline) * Has ADRD or other serious mental illness diagnosis such as schizophrenia as determined by ICD-10 code or self-report * Caregiver is enrolled in an existing ADRD collaborative program at Eskenazi Health, IU Health or the VA. * Caregiver is enrolled in another IU study that is testing a ADRD caregiver intervention

Design outcomes

Primary

MeasureTime frameDescription
Generalized Anxiety Disorder Scale (GAD-7)Baseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-monthThe Generalized Anxiety Disorder Scale (GAD-7) contains 7 items with total scores ranging from 0 to 21. Scores of 5, 10, and 15 are cut-offs for mild, moderate, and severe anxiety, respectively. An add-on item assessing the patient's global impression of symptom-related impairment helps researchers understand the extent to which anxiety interferes in daily life. The GAD-7 has factorial validity for the diagnosis of general anxiety disorder and is sensitive to change.

Other

MeasureTime frameDescription
Zarit Burden InterviewBaseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-monthThe Zarit Burden Interview is a two-factor, 22-item scale that measures personal strain and role strain in caregiving by summing responses to a total score (0-20 little or no burden; 21-40 mild to moderate burden; 41-60 moderate to severe burden; and 61-88 severe burden). The ZBI measures change over time resulting from the progression of the patient's symptoms or from interventions aimed at reducing burden.
Experience of Suffering ScaleBaseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-monthThe Experience of Suffering Scale contains 33 items across 3 subscales: physical (9 items), psychological (15 items), and existential (9 items) suffering. Total scores for each subscale are calculated with higher scores indicating more suffering within each domain.
Multidimensional Psychological Flexibility InventoryBaseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-monthThe 24-item Multidimensional Psychological Flexibility Inventory - Short form measures psychological flexibility and inflexibility. Respondents rate how true each statement is for them on a 6-point Likert-type scale anchored from 1=never true to 6=always true. Higher scores indicate higher levels of the dimension being assessed (i.e., psychological flexibility, psychological inflexibility).
Satisfaction with Life ScaleBaseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-monthThe 5-item Satisfaction with Life Scale measures wellbeing. On a 7-point scale, participants indicate how much they agree or disagree with each of the 5 items to assess cognitive judgments of life satisfaction.
Patient Health Questionnaire-8Baseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-month8-item Patient Health Questionnaire-8 assesses depressive symptoms. With total scores ranging from 0 to 24, scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression, respectively. The PHQ-8 has factorial validity for the diagnosis of major depressive disorder.
Intervention AcceptabilityPost-intervention (7-9 weeks post-baseline)Intervention acceptability is measured at T2 using an investigator-created 5-item measure of quantitative and qualitative satisfaction items.
Health Care and Resource UtilizationBaseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-monthHealth care and resource utilization will be measured using an investigator-created 8-item measure. Items will assess caregiver-reported health and mental care utilization (e.g., emergency department \[ED\], inpatient, outpatient) and services accessed or used to support their caregiving (e.g., support groups, respite care, in-home aid).
Inventory of Complicated GriefBaseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-month ICG will (only) be measured in participants who have their loved one with dementia die during the study and agree to this surveyThe 19-item Inventory of Complicated Grief measures post death grief and bereavement in participants who have lost their loved one with dementia during the study. Each item is rated on a 5-point Likert scale with responses ranging from never to always.
Anticipatory griefBaseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-month AGS will (only) be measured in participants who have their loved one with dementia die during the study and agree to this surveythe Anticipatory Grief Scale (AGS),43 a 27-item self-report tool designed to assess anticipatory grief of dementia caregivers. Items are scored on a 5-point Likert scale with responses ranging from strongly disagree to strongly agree.
Quality of Life in Alzheimer's DiseaseBaseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-monthQuality of Life in Alzheimer's Disease measures caregiver reported measure about the patient's quality of life and will provide preliminary data on the potential impact of the intervention on the person with ADRD for whom enrolled caregiver is caring for.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026